Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pancreatic Cancer Treatment Market
Pancreatic Cancer Treatment Market was valued at USD 3 billion in 2023 and is anticipated to witness growth at a CAGR of 13.2% over the analysis period. Increasing prevalence of pancreatic cancer globally has created a pressing demand for effective treatment options.
For instance, as per the World Cancer Research Fund International, pancreatic cancer is the 12th most common cancer worldwide and there were more than 495,000 new cases of pancreatic cancer in 2020. Such high number of pancreatic cancer cases increases the demand for effective treatments, thereby propelling the market growth. Additionally, the expanding geriatric population, which is more susceptible to pancreatic cancer, also contributes to market growth. Moreover, significant investments in research and development by pharmaceutical companies have resulted in innovative treatments, including targeted therapy and cancer immunotherapy, further fostering a favorable environment for market expansion.
Pancreatic cancer treatment involves various approaches aimed at eradicating or controlling the growth of cancer cells in the pancreas. The treatment involves a multidisciplinary approach that includes chemotherapy, targeted therapy, radiotherapy, surgery, and supportive care. The specific treatment options depend on the stage of the cancer at diagnosis.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Pancreatic Cancer Treatment Market Size in 2023: | USD 3 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 13.2% |
2032 Value Projection: | USD 9.2 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 185 |
Tables, Charts & Figures: | 322 |
Segments covered: | Cancer Type, Treatment Type, Route of Administration, Gender, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|